BRIEF published on 11/13/2025 at 19:45, 10 months 17 days ago Lancement d'une augmentation de capital par MaaT Pharma Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF published on 11/13/2025 at 19:45, 10 months 17 days ago MaaT Pharma launches a capital increase Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
PRESS RELEASE published on 11/13/2025 at 19:40, 10 months 17 days ago Informations privilégiées / Autres communiqués MaaT Pharma lance une augmentation de capital de 9 millions d'euros pour financer son développement. Offre d'actions nouvelles aux investisseurs. Projets de développement clinique et commercialisation Développement Augmentation De Capital Commercialisation Actions Nouvelles MaaT Pharma
PRESS RELEASE published on 11/13/2025 at 19:40, 10 months 17 days ago Inside Information / Other news releases MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026 Private Placement Investment Capital Increase MaaT Pharma Xervyteg
BRIEF published on 11/05/2025 at 07:35, 10 months 26 days ago MaaT Pharma Reveals Promising Preclinical Data for MaaT034 Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
BRIEF published on 11/05/2025 at 07:35, 10 months 26 days ago MaaT Pharma dévoile des données précliniques prometteuses pour MaaT034 Immunothérapie Traitement Du Cancer MaaT Pharma Thérapie Du Microbiome MaaT034
PRESS RELEASE published on 11/05/2025 at 07:30, 10 months 26 days ago Inside Information / Other news releases MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
PRESS RELEASE published on 11/05/2025 at 07:30, 10 months 26 days ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données précliniques actualisées pour MaaT034 au Congrès SITC, démontrant activation immunitaire et activité anti-tumorale MaaT Pharma Données Précliniques MaaT034 Activation Immunitaire Congrès SITC
BRIEF published on 11/04/2025 at 11:43, 10 months 26 days ago MaaT Pharma Receives BUY Rating from First Berlin Equity Research Biotechnology Clinical Trials Investment Cancer Treatment Microbiome Therapy
BRIEF published on 11/04/2025 at 11:43, 10 months 26 days ago MaaT Pharma reçoit une recommandation d'achat de la part de First Berlin Equity Research. Investissement Biotechnologie Essais Cliniques Traitement Du Cancer Thérapie Du Microbiome
Published on 10/01/2026 at 08:02, 55 minutes ago Southern Energy Announces Results of Annual Meeting and Board Changes
Published on 10/01/2026 at 01:21, 7 hours 36 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 7 hours 57 minutes ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 9 hours 27 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 12 hours 22 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 10/01/2026 at 08:35, 22 minutes ago European consumers dissatisfied with rising costs in cross-border online shopping reveals Nielsen IQ study, commissioned by agency KleinS
Published on 10/01/2026 at 08:33, 23 minutes ago Lenzing AG launches fully underwritten capital increase with subscription rights
Published on 10/01/2026 at 08:30, 27 minutes ago Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 27 minutes ago Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat
Published on 10/01/2026 at 08:30, 27 minutes ago Eurazeo ouvre un bureau à Abu Dhabi et renforce son engagement au Moyen-Orient
Published on 10/01/2026 at 08:00, 57 minutes ago CNP Assurances and Embracon complete their combination to create a leading consórcio player in Brazil
Published on 10/01/2026 at 08:00, 57 minutes ago CNP Assurances et Embracon finalisent leur rapprochement pour former un acteur majeur du consórcio au Brésil
